Evidence Hub

Delayed-Onset Hypoglycemia After Levofloxacin Use in a Diabetic Patient

Henry A Dwaah, Sarah Tupchong, Joseph M. Kim

Case Reports in Medicine, 2025

1 citation

Abstract

We discuss the case of a patient with diabetes on long-term glipizide and stable glucose management who presented with delayed-onset hypoglycemia 6 weeks after initiating levofloxacin for osteomyelitis. The patient presented with neuroglycopenic symptoms, including dysarthria, slurred speech, and syncopal episodes. Serum glucose level was 35 mg/dL, and C-peptide was markedly elevated at 12.42 ng/mL. Hypoglycemia resolved immediately after D50 administration. Discontinuation of glipizide while on levofloxacin did not result in any new hypoglycemic episodes. In previously documented cases, hypoglycemia occurred within days or less than a week after initiating levofloxacin. This report represents an interesting case of delayed-onset hypoglycemia after initiating levofloxacin in a stably managed diabetic patient on long-term glipizide secretagogue.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free